Officer Margaret Horn Files to Sell $470k in Revolution Medicines Stock
Revolution Medicines, Inc.
Subscribe to track RVMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Officer Margaret Horn Files to Sell $470k in Revolution Medicines Stock
Company: Revolution Medicines, Inc. Form: 144 | Filed: 2026/03/13 Significance: Low
Insider: Horn Margaret A Relationship: Officer
Transaction: • Type: Proposed Sale • Shares: 4,722 • Value: $470,263.98 • Date: 03/16/2026 (Approx)
Key Insight: Routine sale of shares originally acquired via RSU grants. Represents a negligible 0.002% of market cap. Executed under a 10b5-1 plan adopted in May 2023.
Market Context: Transaction is immaterial relative to the company's $19.69B market cap.
Comprehensive Analysis
SEC Filing Analysis: Revolution Medicines, Inc.
Executive Summary
- Trading Significance: Low
- Key Takeaway: Officer files to sell ~$470k in stock derived from RSU grants under a pre-arranged 10b5-1 plan.
- Market Impact: Negligible; transaction represents ~0.002% of market cap.
Company Information
| Field | Value |
|---|---|
| Company | Revolution Medicines, Inc. |
| CIK | 0001628171 |
| Industry | Biological Products |
Insider Information
| Field | Value |
|---|---|
| Name | Horn Margaret A |
| CIK | 0001294192 |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Approx Sale Date | 03/16/2026 |
| Transaction Code | S (Proposed) |
| Security Type | Common Stock |
| Shares Involved | 4,722 |
| Price Per Share | ~$99.59 (Implied) |
| Total Value | $470,263.98 |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $470,263.98 |
| % of Market Cap | 0.0024% |
| Shares Transacted | 4,722 |
| % of Shares Outstanding | 0.0024% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: With a market cap of $19.69 billion, a $470k transaction is statistically irrelevant and likely routine liquidity management.
- Dilution Impact: None; these are existing shares being sold into the market.
- Transaction Significance: The transaction volume is extremely low relative to the float (193M+ shares outstanding).
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The sale is too small to impact price mechanics and is conducted under a 10b5-1 plan, removing signaling risk.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral. The sale follows a much larger $7.5M disposition in January 2026, suggesting this specific tranche is likely related to recent RSU vesting (March 1st dates cited in filing).
Additional Context
Transaction Notes
- Source of Shares: Shares were acquired via Restricted Stock Unit (RSU) grants vesting between 2022 and 2025.
- 10b5-1 Plan: The sale is pursuant to a plan adopted on 05/31/2023, indicating this was a scheduled, non-discretionary trade.
- Recent Activity: The reporting person sold significantly more stock ($7.5M) in January 2026; this current filing appears to be a minor cleanup or tax-related sale.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.